Gold Bond Medicated eczema relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gold Bond Medicated eczema relief
Generic name: COLLOIDAL OATMEAL
Manufacturer: Gold Bond Co LLC
Product type: HUMAN OTC DRUG
SPL set ID: c292e443-7418-4679-b9b2-4e6d96c04c4c
SPL ID: 4c1fe137-c53d-4b62-b0fd-a56b1828fe52
Version: 1
Effective date: 2025-12-05
Source export date: 2026-10-12
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b8dac220ac9fc8ffb4d86c6e00ece30169fc4575ca0cc92e5c9ce1a524fb0249/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 03:10:54

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M016	openfda.application_number
brand name		Gold Bond Medicated eczema relief	openfda.brand_name
generic name		COLLOIDAL OATMEAL	openfda.generic_name
manufacturer name		Gold Bond Co LLC	openfda.manufacturer_name
ndc	package	84714-0567-1	openfda.package_ndc
ndc	product	84714-0567	openfda.product_ndc
ndc11	package	84714056701	derived:openfda.package_ndc
rxcui		1189915	openfda.rxcui
spl id		4c1fe137-c53d-4b62-b0fd-a56b1828fe52	id
spl set id		c292e443-7418-4679-b9b2-4e6d96c04c4c	set_id
unii		8PI54V663Y	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this produc t avoid contact with eyes Stop use and ask a doctor if condition worsens symptoms persist for more than 7 days or clear up and occur again within a few days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.